Naltrexone depot (DrugAbuse Sciences).
DrugAbuse Sciences is developing naltrexone depot, a sustained-release (SR) injectable formulation of naltrexone for the potential treatment of alcoholism and opiate addiction. This formulation was developed to help alcoholics and heroin addicts overcome the problems with compliance experienced with the daily-administered tablet form of naltrexone [322165]. Phase III trials of naltrexone depot for the treatment of alcoholics and phase II trials of naltrexone depot for injectable suspension (Naltrel) for the treatment of opiate addiction are ongoing [426301].
Modesto-Lowe
Vania
V
Alcohol Research Center, Department of Psychiatry, University of Connecticut Health Center, Farmington, CT 06030, USA. modesto@psychiatry.uchc.edu